ZofiaPiotrowskaMD

PubMed

• 655 citations
  Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition
  Aaron N. Hata, Matthew J. Niederst, Hannah L. Archibald, Maria Gomez-Caraballo, Faria M. Siddiqui
  Nature Medicine. 2016-03-01
• 41 citations
  Acquired Resistance of EGFR-Mutated Lung Cancer to Tyrosine Kinase Inhibitor Treatment Promotes PARP Inhibitor Sensitivity.
  Lynnette Marcar, Kankana Bardhan, Liliana Gheorghiu, Patrick H Dinkelborg, Heike N. Pfäffle
  Cell Reports. 2019-06-18
• 12 citations
  Safety, Tolerability, and Antitumor Activity of Zipalertinib Among Patients With Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Exon 20 Insertions.
  Zofia Piotrowska, Daniel Shao-Weng Tan, Egbert F Smit, Alexander I Spira, Ross A Soo
  Journal of Clinical Oncology. 2023-09-10

Journal Articles

• Oxford University Press Has Registered This DOI Pre-Publication  
  R S Heist, Z Piotrowska, C G Azzoli, A T Shaw, I T Lennes, L V Sequist, J F Gainor, Oxford University Press
• EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung Adenocarcinomas  
  Lecia V Sequist, Zofia Piotrowska, Clinical Cancer Research

Lectures

• Clinical outcomes of EGFR+ NSCLC pts treated with immune checkpoint inhibitors (ICI). 
  2019 ASCO Annual Meeting - 6/1/2019
• Clinical Features of Immune Checkpoint Inhibitor-Associated Autoimmune Hemolytic Anemia: A Series of 14 Cases 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018